Xylyx Bio, a regenerative medicine company, and Alec Batis, a renowned product innovator and research chemist, have formed a strategic collaboration to bring Sweet Chemistry Evidence-Based Regenerative Skincare to market.
Sweet Chemistry represents an alliance at the intersection of science and beauty by integrating Xylyx Bio’s clinically proven Matrikynes® regenerative peptides with Alec Batis’ expertise in cosmetic science to create a transformative brand that transcends conventional skincare approaches. Matrikynes® are clinically proven to improve the structure, function, and appearance of damaged and aging skin.
Science-based skincare is a large and growing market segment as consumers seek products backed by data, research, and reliable information, with increasing demand for products that provide visible improvements coupled with transparency about ingredients and formulations that allow consumers to make informed choices.
“Xylyx Bio is driven by the pursuit of scientific innovation and a vision to redefine skincare through insights gained in regenerative medicine,” said Andrea Nye, CEO of Xylyx Bio. “By collaborating with Alec Batis, we are combining the reparative capabilities of Matrikynes® with cosmetic excellence to introduce a new era in skincare.”
Alec Batis stated, “Teaming up with Xylyx Bio has been an incredible journey of merging cutting-edge scientific research with cosmetic science and formulation artistry. Sweet Chemistry reflects our dedication to innovating exceptionally evolved skincare products.”
Sweet Chemistry is launching with two products, the Elasticity Reinforcing Cream and Reparative Oil-Serum Infusion. Each formulation boasts the highest standard of quality and efficacy. Products are dermatologist-tested, cruelty-free, and free from harmful chemicals, aligning with the partnership’s shared commitment to sustainability and ethical practices.
